PMID: 26822906DOI: 10.1016/j.bulcan.2015.12.003Jan 30, 2016Paper
Ibrutinib prescription in B-cell lymphoid neoplasms
Bulletin du cancer
Aurore DougéRichard Lemal
Abstract
Ibrutinib is a new-targeted therapy that irreversibly and specifically inhibits the Bruton's Tyrosine Kinase (BTK), a key component of the signaling pathways of B cells. The results are very encouraging as monotherapy in the treatment of chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia. Following the results of recent studies, ibrutinib is now available in France for these three diseases.
References
Jan 24, 2007·Immunity·David J J de GorterMarcel Spaargaren
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Lee A HonigbergJoseph J Buggy
Dec 20, 2011·Blood·Sabine PonaderJan A Burger
Oct 10, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ranjana H AdvaniNathan H Fowler
Mar 19, 2013·Expert Opinion on Pharmacotherapy·Osmond J D'Cruz, Fatih M Uckun
May 31, 2013·American Journal of Hematology·Michael Hallek
Jun 21, 2013·The New England Journal of Medicine·Michael L WangKristie A Blum
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Aug 14, 2013·Blood·Betty Y ChangLaurence Elias
Dec 18, 2013·The Lancet Oncology·Susan O'BrienJohn C Byrd
Jan 30, 2014·Experimental Hematology & Oncology·Aileen NoveroDelong Liu
Mar 25, 2014·Nature Reviews. Cancer·Rudi W HendriksLaurens P Kil
May 24, 2014·Leukemia·M DreylingO Hermine
Jun 3, 2014·The New England Journal of Medicine·John C ByrdUNKNOWN RESONATE Investigators
Jul 22, 2014·The Lancet Oncology·Anas YounesYasuhiro Oki
Aug 2, 2014·Cancer Discovery·David ChironSelina Chen-Kiang
Aug 26, 2014·The Lancet Oncology·Jan A BurgerSusan O'Brien
Oct 11, 2014·Blood·Peter DregerUNKNOWN European Research Initiative on CLL (ERIC) and the European Society for Blood and Marrow Transplantation (EBMT)
Oct 12, 2014·Blood·Marie LevadeBernard Payrastre
Oct 31, 2014·Blood·Kami MaddocksKristie A Blum
Nov 2, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex F Herrera, Eric D Jacobsen
Nov 6, 2014·British Journal of Haematology·Yang CaoSteven P Treon
Jan 4, 2015·The Lancet Oncology·Mohammed Z H FarooquiAdrian Wiestner
Feb 24, 2015·Blood·John C ByrdSusan O'Brien
Feb 26, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Y CheahM L Wang
Mar 11, 2015·Blood·Jennifer R BrownSusan O'Brien
Apr 11, 2015·British Journal of Haematology·Shuang Q ZhangYue Lynn Wang
May 24, 2015·Blood·Steven P Treon
Jun 11, 2015·Blood·Michael L WangSimon Rule
Jun 13, 2015·Blood·Jennifer A Woyach, Amy J Johnson
Jun 28, 2015·Blood·Samantha M JaglowskiJohn C Byrd
Jul 17, 2015·JAMA Oncology·Kami J MaddocksJennifer A Woyach
❮ Previous
Next ❯
Related Concepts
Related Feeds
B-Cell Leukemia (Keystone)
B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.
Related Papers
Leukemia & Lymphoma
Jennifer R Brown
Zhongguo shi yan xue ye xue za zhi
Man WangJian-Yong Li
Cancer Chemotherapy and Pharmacology
Eleonora MarosticaItalo Poggesi
Journal of the Advanced Practitioner in Oncology
Derek Peterson, Joanna Schwartz
Expert Opinion on Pharmacotherapy
Mitchell R Smith